Perlman, Elizabeth

Perlman, Elizabeth was paid $20.05M by Medicaid between Jan 2018 and Apr 2024, across 222 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 21% of everything it billed.

Compared with peers

Next to other Clinical Pathology/Laboratory Medicine Physician providers in Illinois

Rank by total paid#1 of 34

Median peer was paid$104K

This provider vs. median193×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	294,710	$1.72M
2019	373,427	$2.28M
2020	412,194	$3.23M
2021	415,203	$4.80M
2022	416,424	$4.77M
2023	365,680	$2.84M
2024incomplete	74,326	$409K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	21%	64,342	50,528	$4.13M
0202U	Oncology (prostate), multianalyte, gene expression profiling	6.9%	5,369	4,531	$1.39M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	4.2%	5,780	5,077	$834K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.6%	222,663	119,292	$716K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.2%	3,654	3,032	$642K
82803		3.2%	52,805	14,203	$642K
82330		3.1%	71,279	21,024	$618K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	3.0%	3,911	3,415	$601K
80053	Comprehensive metabolic panel	2.9%	104,116	71,667	$576K
83735		2.4%	117,772	31,255	$478K
87631		2.3%	8,540	8,086	$461K
80069		2.0%	89,753	26,693	$407K

210 more codes

84443	Thyroid stimulating hormone (TSH)	1.7%	37,404	$333K
80048	Basic metabolic panel (calcium, ionized)	1.4%	68,076	$290K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.4%	11,850	$287K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.3%	4,471	$264K
87040		1.3%	30,087	$262K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.3%	9,847	$257K
83605		1.2%	33,596	$248K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	1.1%	5,149	$222K
87799		1.1%	7,968	$212K
87641		1.0%	8,980	$207K
84439		<1%	36,842	$177K
87497		<1%	6,691	$166K
83970		<1%	9,690	$164K
0240U		<1%	1,078	$161K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	21,251	$140K
87086	Culture, bacterial; quantitative colony count, urine	<1%	24,538	$140K
83880		<1%	12,799	$139K
80197		<1%	22,575	$128K
85730		<1%	32,747	$125K
86140		<1%	47,714	$124K
82610		<1%	20,711	$116K
82784		<1%	15,595	$112K
84100		<1%	54,867	$112K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	4,283	$111K
80076		<1%	24,232	$87K
87186		<1%	13,127	$87K
85610		<1%	36,997	$86K
83036	Hemoglobin; glycosylated (A1C)	<1%	22,487	$83K
82375		<1%	20,984	$79K
85130		<1%	9,686	$76K
86885		<1%	22,730	$76K
81003		<1%	56,754	$75K
87493		<1%	3,016	$75K
82728		<1%	17,620	$75K
86003		<1%	6,473	$71K
80061	Lipid panel	<1%	20,956	$69K
82962		<1%	36,565	$65K
86355		<1%	3,500	$63K
86357		<1%	3,498	$62K
86160		<1%	5,975	$59K
86901		<1%	22,799	$59K
82570		<1%	21,096	$57K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,286	$56K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,284	$56K
81001		<1%	35,915	$56K
83001		<1%	5,435	$55K
83516		<1%	5,467	$53K
84145		<1%	4,147	$53K
86945		<1%	11,289	$53K
85384		<1%	15,121	$52K
86360		<1%	4,225	$52K
83050		<1%	20,957	$52K
87070		<1%	15,987	$51K
80074		<1%	2,336	$50K
84703		<1%	10,819	$45K
86900		<1%	22,798	$44K
83550		<1%	9,270	$43K
80202		<1%	5,665	$43K
85652		<1%	29,382	$42K
82533		<1%	4,678	$41K
86359		<1%	4,028	$40K
82248		<1%	20,320	$38K
85378		<1%	9,168	$38K
85045		<1%	27,419	$37K
86038		<1%	4,240	$36K
83540		<1%	10,231	$36K
83690		<1%	9,252	$34K
83002		<1%	5,864	$33K
89051		<1%	9,436	$32K
87205		<1%	15,690	$32K
86665		<1%	1,523	$31K
84403		<1%	2,271	$31K
83615		<1%	11,283	$31K
82977		<1%	13,378	$30K
86985		<1%	6,419	$30K
85018		<1%	21,304	$30K
82550		<1%	10,142	$30K
84295		<1%	12,419	$29K
86225		<1%	4,172	$28K
87536		<1%	583	$28K
86008		<1%	1,474	$26K
82140		<1%	5,053	$26K
82247		<1%	13,614	$26K
87081		<1%	7,489	$25K
87015		<1%	6,098	$25K
87483		<1%	125	$25K
82785		<1%	5,272	$25K
84460		<1%	11,442	$25K
87507		<1%	134	$24K
80195		<1%	4,977	$24K
86376		<1%	5,100	$23K
87427		<1%	3,392	$23K
86800		<1%	3,712	$23K
87045		<1%	3,372	$23K
84146		<1%	3,009	$23K
85027		<1%	7,164	$22K
84156		<1%	17,046	$22K
86162		<1%	2,272	$21K
82397		<1%	2,856	$21K
84075		<1%	9,773	$21K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,333	$20K
82105		<1%	2,248	$20K
84132		<1%	10,364	$20K
84480		<1%	4,113	$20K
81025		<1%	10,324	$20K
86922		<1%	1,758	$19K
84450		<1%	9,080	$18K
83525		<1%	3,621	$18K
86235		<1%	1,053	$18K
86706		<1%	2,278	$17K
86146		<1%	554	$17K
84478		<1%	9,275	$16K
82139		<1%	2,539	$16K
82947		<1%	8,917	$16K
82565		<1%	6,706	$16K
85246		<1%	2,574	$15K
86902		<1%	2,376	$15K
84484		<1%	3,183	$14K
86364		<1%	1,779	$13K
87046		<1%	3,437	$12K
80164		<1%	2,451	$12K
84155		<1%	7,625	$12K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	388	$12K
82435		<1%	5,756	$11K
86645		<1%	1,041	$11K
82043		<1%	4,929	$11K
86803		<1%	1,082	$10K
86774		<1%	963	$10K
86147		<1%	573	$10K
86880		<1%	1,886	$10K
87425		<1%	1,045	$10K
80184		<1%	1,773	$10K
87075		<1%	1,329	$10K
82379		<1%	1,573	$10K
87077		<1%	6,499	$9K
84300		<1%	4,261	$9K
82436		<1%	3,821	$9K
82010		<1%	2,347	$9K
85347		<1%	2,392	$9K
85660		<1%	2,702	$9K
82150		<1%	2,477	$9K
86592		<1%	3,822	$8K
82945		<1%	4,810	$8K
84133		<1%	3,837	$8K
84550		<1%	4,016	$8K
83520		<1%	1,179	$8K
87116		<1%	1,132	$8K
84702		<1%	1,475	$8K
85240		<1%	1,278	$7K
87102		<1%	1,975	$7K
86644		<1%	940	$7K
84157		<1%	4,855	$6K
84030		<1%	2,269	$6K
83919		<1%	656	$5K
87340		<1%	753	$5K
87529		<1%	159	$5K
87206		<1%	1,793	$5K
86769		<1%	153	$4K
85245		<1%	661	$4K
85014		<1%	3,389	$4K
84510		<1%	700	$4K
88264		<1%	45	$4K
80050	General health panel	<1%	981	$4K
88237		<1%	59	$3K
82232		<1%	654	$3K
83930		<1%	1,078	$3K
86258		<1%	202	$3K
82310		<1%	1,489	$3K
82103		<1%	506	$3K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	300	$2K
86430		<1%	638	$2K
84134		<1%	520	$2K
84520		<1%	1,169	$2K
86787		<1%	224	$2K
83003		<1%	198	$2K
86920		<1%	317	$2K
87150		<1%	34	$2K
86923		<1%	4,267	$1K
88230		<1%	30	$1K
80051		<1%	358	$1K
82040		<1%	908	$1K
88262		<1%	14	$952.05
86684		<1%	70	$929.04
86308		<1%	363	$908.88
83935		<1%	337	$862.96
82465		<1%	747	$855.79
83655		<1%	132	$824.71
87496		<1%	31	$741.96
85396		<1%	77	$646.61
86015		<1%	75	$546.91
84080		<1%	130	$544.53
87185		<1%	189	$514.26
82044		<1%	214	$458.01
82272		<1%	365	$457.08
87149		<1%	67	$435.57
86905		<1%	68	$419.38
86860		<1%	39	$246.45
88280		<1%	15	$209.31
86927		<1%	396	$192.00
86870		<1%	17	$162.06
86431		<1%	43	$161.44
82136		<1%	24	$129.44
85300		<1%	23	$107.17
82438		<1%	41	$106.08
84436		<1%	34	$103.22
86704		<1%	12	$98.94
87184		<1%	13	$66.60
83718		<1%	16	$61.34
0353U		0%	55	$0.00
0099U		0%	1,238	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.